Jiangsu, China

Zenghui Yu

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Zenghui Yu: A Spotlight on His Patent Contributions

Introduction: Zenghui Yu, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of pharmaceuticals. With a keen interest in compounds that inhibit cell proliferation, his work holds promise for treating various clinical conditions associated with uncontrolled cell growth.

Latest Patents: Zenghui Yu is credited with one notable patent titled "3-aryl-6-aryl-[1,2,4]triazolo[4,3-α]pyridines as inhibitors of cell proliferation and the use thereof." This innovative patent discloses compounds represented by the Formula (I), where Ar, Ar, R, and R are specifically defined. The compounds described are effective inhibitors of cell proliferation, suggesting their potential use in therapies aimed at managing diseases characterized by the abnormal growth and spread of cells.

Career Highlights: Throughout his career, Zenghui Yu has dedicated himself to research and development in the pharmaceutical industry. His innovative mind has contributed to the advancement of treatment methodologies, focusing on critical health issues that affect many individuals globally.

Collaborations: In his pursuit of innovation, Zenghui Yu has collaborated with esteemed colleagues such as Suixiong Cai and Ye Edward Tian. These partnerships reflect a collaborative effort within the research community, aiming to enhance the efficacy of treatments against cancer and other proliferative diseases.

Conclusion: Zenghui Yu's contributions to the field of pharmaceuticals, particularly through his patented inventions, illustrate his commitment to innovation in healthcare. His work exemplifies the potential of scientific research in addressing critical medical challenges, paving the way for future developments in the treatment of diseases marked by uncontrolled cell proliferation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…